Cargando…

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China

China’s hepatitis B virus (HBV) prevention policy has been evaluated through nationally representative serologic surveys conducted in 1992 and 2006. We report results of a 2014 serologic survey and reanalysis of the 1992 and 2006 surveys in the context of program policy. The 2014 survey used a 2-sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Fuqiang, Shen, Lipin, Li, Li, Wang, Huaqing, Wang, Fuzhen, Bi, Shengli, Liu, Jianhua, Zhang, Guomin, Wang, Feng, Zheng, Hui, Sun, Xiaojin, Miao, Ning, Yin, Zundong, Feng, Zijian, Liang, Xiaofeng, Wang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403029/ https://www.ncbi.nlm.nih.gov/pubmed/28418296 http://dx.doi.org/10.3201/eid2305.161477

Ejemplares similares

Self-motivated medical care-seeking behaviors and disease progression in a community-based cohort of chronic hepatitis B virus-infected patients in China
por: Zheng, Hui, et al.
Publicado: (2019)

Enhanced sentinel surveillance for hepatitis B infection in 200 counties in China, 2013-2016
por: Miao, Ning, et al.
Publicado: (2019)

Acute Hepatitis B — China, 2005−2019
por: Miao, Ning, et al.
Publicado: (2020)

Progress Towards Hepatitis A Control and Prevention Through 2019: the National Immunization Program of China
por: Sun, Xiaojin, et al.
Publicado: (2020)

Complete genome analysis of hepatitis B virus in Qinghai-Tibet plateau: the geographical distribution, genetic diversity, and co-existence of HBsAg and anti-HBs antibodies
por: Liu, He, et al.
Publicado: (2020)

Hepatitis B vaccination coverage among health care workers in China
por: Yuan, Qianli, et al.
Publicado: (2019)

Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China
por: Miao, Ning, et al.
Publicado: (2020)

Whole-gene analysis of two groups of hepatitis B virus C/D inter-genotype recombinant strains isolated in Tibet, China
por: Liu, Tiezhu, et al.
Publicado: (2017)

Using a hepatitis B surveillance system evaluation in Fujian, Hainan, and Gansu provinces to improve data quality and assess program effectiveness, China, 2015
por: Zheng, Hui, et al.
Publicado: (2020)

Correction to: Using a hepatitis B surveillance system evaluation in Fujian, Hainan, and Gansu provinces to improve data quality and assess program effectiveness, China, 2015
por: Zheng, Hui, et al.
Publicado: (2020)

Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China
por: An, Zhijie, et al.
Publicado: (2021)

Effects of Three Major Immunization Interventions on Measles Control — China, 1952–2021
por: Song, Quanwei, et al.
Publicado: (2023)

Development, Production, and Postmarketing Surveillance of Hepatitis A Vaccines in China
por: Cui, Fuqiang, et al.
Publicado: (2014)

Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis
por: Xu, Shiyao, et al.
Publicado: (2023)

Vaccination Guidelines During and After the COVID-19 Epidemic in China
por: Yu, Wenzhou, et al.
Publicado: (2020)

Estimating the impact of test-and-treat strategies on hepatitis B virus infection in China by using an age-structured mathematical model
por: Zu, Jian, et al.
Publicado: (2018)

Estimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental model
por: Zu, Jian, et al.
Publicado: (2017)

Effectiveness of Catch-Up Vaccinations after COVID-19 Containment — China, 2020
por: Wu, Jing, et al.
Publicado: (2020)

Epidemiology of Hepatitis E Virus in China: Results from the Third National Viral Hepatitis Prevalence Survey, 2005–2006
por: Jia, Zhiyuan, et al.
Publicado: (2014)

Vaccine-preventable disease control in the People’s Republic of China: 1949–2016
por: Yu, Wenzhou, et al.
Publicado: (2018)

Progress Toward Measles Elimination — China, January 2013–June 2019
por: Ma, Chao, et al.
Publicado: (2019)

Progress Toward Measles Elimination — China, January 2013-June 2019
por: Ma, Chao, et al.
Publicado: (2019)

Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China
por: Zhang, Li, et al.
Publicado: (2018)

Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial
por: Li, Yan, et al.
Publicado: (2021)

Hepatitis A Surveillance and Vaccine Use in China From 1990 Through 2007
por: Cui, Fuqiang, et al.
Publicado: (2009)

Vaccinate with Confidence and Finish Strong
por: Rodewald, Lance, et al.
Publicado: (2022)

The National Immunization Advisory Committee in China: Roles of National Experts in Making Evidence-Based Recommendations for Immunization
por: Ma, Chao, et al.
Publicado: (2019)

Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis
por: Song, Yue, et al.
Publicado: (2023)

Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants — China, May 21, 2021–February 28, 2022
por: Li, Mingshuang, et al.
Publicado: (2022)

Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Hebei Province, China, November 2018 to November 2020
por: Li, Yan, et al.
Publicado: (2023)

Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
por: Wang, Fuzhen, et al.
Publicado: (2021)

Escalation of Coronary Atherosclerosis in Younger People by Comparison of Two Autopsy Studies Conducted a Decade Apart
por: Venkatesh, Kusuma, et al.
Publicado: (2018)

Escalating complexity of endoscopic retrograde cholangiopancreatography over the last decade with increasing reliance on advanced cannulation techniques
por: Barakat, Monique T, et al.
Publicado: (2020)

Conclusion: The Next Decade of Family Policy Research
por: Van Lancker, Wim, et al.
Publicado: (2020)

Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control
por: Yan, Bingyu, et al.
Publicado: (2023)

Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial
por: Wang, Yamin, et al.
Publicado: (2021)

Evaluating the independent influence of sexual transmission on HBV infection in China: a modeling study
por: Li, Miaolei, et al.
Publicado: (2021)

Real de-escalation or escalation in disguise?
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2023)

Secular trends of epidemiologic patterns of chronic kidney disease over three decades: an updated analysis of the Global Burden of Disease Study 2019
por: Feng, Xiaojin, et al.
Publicado: (2023)

The effects of different dosage levels of hepatitis B vaccine as booster on anti-HBs-negative children 5–15 y after primary immunization; China, 2009–2010
por: Chen, Yongdi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tekjitjmib0erdtc21cn74ogmn